Drug Shortage Report for APO-BICALUTAMIDE
| Report ID | 20860 |
| Drug Identification Number | 02296063 |
| Brand name | APO-BICALUTAMIDE |
| Common or Proper name | BICLUTAMIDE |
| Company Name | APOTEX INC |
| Market Status | DORMANT |
| Active Ingredient(s) | BICALUTAMIDE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 BLS |
| ATC code | L02BB |
| ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-10-20 |
| Actual start date | 2017-09-22 |
| Estimated end date | 2018-09-14 |
| Actual end date | 2018-08-22 |
| Shortage status | Resolved |
| Updated date | 2018-08-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-09-04 | French | Compare |
| v1 | 2017-09-04 | English | Compare |